Conference Speakers

Dr. Shebuski has over 25 years experience in the pharmaceutical industry and served as the Director of Cardiovascular Therapeutics at Pharmacia & Upjohn in Kalamazoo, MI from 1990-1998. He established a Cardiovascular Research Consulting Firm in 1998 and continues to serve small, mid and large pharma in many aspects of drug discovery and development. Additionally, Dr. Shebuski founds and manages start-up biotech companies. He served as the VP of Pre-Clinical Research for CarePoint Medical developing a panel of cardiac diagnostic tests to “rule out” acute myocardial infarction (i.e. heart attack). He then joined Afmedica, Inc, a Kalamazoo, MI-based biotech start-up that developed a drug-eluting (sirolimus) polymer product which was placed around surgical graft sites to prevent hemodialysis access and peripheral vascular graft failure. Afmedica was acquired by Angiotech Pharmaceuticals (Vancouver, B.C.). Currently, Dr. Shebuski is President & CEO of Nytricx, Inc. (Athens, GA) developing anti-microbial nitric oxide-releasing medical devices.